Old Mission Capital’s iShares Biotechnology ETF IBB Stock Holding History

Old Mission Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,682	Closed	-$1.3M	–	1175
2025 Q4	$1.3M	Buy	+7,682	New	+$1.25M	0.03%	307
2025 Q3	–	Sell	-1,661	Closed	-$210K	–	1175
2025 Q2	$210K	Buy	+1,661	New	+$204K	﹤0.01%	996
2024 Q4	–	Sell	-21,905	Closed	-$3.19M	–	1037
2024 Q3	$3.19M	Buy	+21,905	New	+$3.17M	0.05%	250
2023 Q4	–	Sell	-3,119	Closed	-$381K	–	1471
2023 Q3	$381K	Buy	+3,119	New	+$397K	0.01%	796
2023 Q1	–	Sell	-18,421	Closed	-$2.42M	–	1564
2022 Q4	$2.42M	Buy	18,421 +12,523	+212%	+$1.62M	0.07%	254
2022 Q3	$690K	Buy	+5,898	New	+$732K	0.02%	507
2022 Q1	–	Sell	-12,065	Closed	-$1.84M	–	1465
2021 Q4	$1.84M	Buy	+12,065	New	+$1.87M	0.08%	263
2021 Q3	–	Sell	-36,037	Closed	-$5.9M	–	1102
2021 Q2	$5.9M	Buy	36,037 +18,034	+100%	+$2.78M	0.2%	96
2021 Q1	$2.71M	Buy	+18,003	New	+$2.86M	0.15%	168
2020 Q3	–	Sell	-4,235	Closed	-$579K	–	502
2020 Q2	$579K	Sell	4,235 -16,111	-79%	-$2.05M	0.04%	256
2020 Q1	$2.19M	Buy	+20,346	New	+$2.34M	0.19%	97

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Old Mission Capital's IBB Position: Q1 2026 in Review

Old Mission Capital sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 7,682 shares — an estimated $1.3M sold.

Old Mission Capital first reported a position in IBB in Q1 2020 and held it in 11 quarters. The position peaked at $5.9M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Old Mission Capital reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Old Mission Capital sold 7,682 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.3M.
Old Mission Capital first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 11 quarters.
Old Mission Capital's iShares Biotechnology ETF position peaked at $5.9M in Q2 2021.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Old Mission Capital's 13F filing for Q1 2026, filed 15 May 2026.